Number of Applicants
:000+
This job is no longer accepting applications.
Scroll down below to view similar jobs .
POSITION SUMMARY:
As Intercept continues to build its position as the leader in rare and serious liver disease, we are seeking a Director, US Commercial Training. The Director, US Commercial Training will primarily be responsible for identifying the training and development needs of the Sales and Market Access teams to support the ongoing evolution of our commercial organization. This position will report into will report to the VP of Operations and Analytics.
This role is accountable for the establishment and management of a learning curriculum including designing, developing various learning opportunities through instructional materials, training courses and multimedia technologies. You will align our learning strategies and programs to business strategies to realize measurable business impact. The role oversees the Associate Director of Sales Training and will collaborate with HR business partners and cross functional business leaders to identify, create, and address gaps in learning. This includes developing and executing a project plan and learning strategy that will guide and manage critical competency enhancements by analyzing, designing, developing, and implementing learning activities.
This role is high impact/high visibility within the US commercial organization. It offers a unique opportunity to shape and enhance the growing organization from the ground level. The successful candidate will need to collaborate closely with other functional and geographical teams across the company including but not limited to Sales, Sales Operations, Marketing, Market Access, Market Insights, Human Resources, Regulatory, Legal/Compliance and Medical Affairs.
For virtually located candidates, role is expected to be present in NJ HQ office at least one week per month.
CORE ACCOUNTABILITIES:
The successful candidate must be able to perform each of the following satisfactorily, with or without an accommodation:
Requirements
QUALIFICATIONS:
REQUIRED KNOWLEDGE AND ABILITIES:
Benefits
COMPANY CULTURE:
People at Intercept are passionate about patients. You’ll see our patient photos lining our walls and hear their stories in town halls. We’re equally passionate about our team and ensuring each member from all dimensions of diversity feels included and has the opportunity to reach their potential. We recognize the power of a diverse, equitable and inclusive (DEI) work force, and how it enriches the professional lives of our team members. Diversity, Equity, and Inclusion drives innovation and connects us to the patients and communities we serve.
At Intercept, we foster an environment that celebrates creativity, collaboration, and mutual respect. We never hesitate to lean on our teammates and work together. As we grow, we want to make every effort to provide a safe and open environment for professionals of every background and provide knowledge on how to work inclusively and equitably to make Intercept a great place to work.
Our relatively small size means you partner with accessible leaders who know you by name. This brings accountability and growth, which all add up to more opportunities to learn something new every day. For self-motivated leaders who are ready to make a difference in the lives of patients, Intercept is a great place to be.
COMPANY SUMMARY:
Intercept is a biopharmaceutical company with a mission to build a healthier tomorrow for people living with rare and serious liver diseases. Intercept’s lead product, obeticholic acid (OCA), is a first-in-class farnesoid X receptor (FXR) agonist marketed under the brand name “Ocaliva®” in the U.S., EU and Canada for the treatment of patients with primary biliary cholangitis (PBC), a rare autoimmune liver disease. In 2016, Ocaliva® was the first medication to be approved for PBC in over twenty years, and sales continue to grow.
Intercept continues to build on our ongoing commitment to people living with PBC by progressing our research portfolio with a novel fixed-dose combination of OCA and bezafibrate. Phase 2 analyses of this combination were presented at the European Association for the Study of the Liver (EASL) congress in June of 2023 and the American Association for the Study of Liver Diseases (AASLD)’s The Liver Meeting in November of 2023.Further, we are leveraging our decades of research and background in bile acids and FXR agonism to expand our pipeline in other liver diseases, such as severe alcohol-associated hepatitis (sAH).
COMPENSATION & BENEFITS:
The anticipated starting salary range for this position is $190,000 to $230,000. This represents the anticipated low and high end of the salary range for this position. Actual salaries will vary and may be above or below the range, based on various factors including, but not limited to, experience, skillset, and performance.
The salary range listed is just one component of our total compensation package. Successful applicants will also be eligible to receive annual bonuses at the discretion of the Company. Intercept also provides a competitive suite of benefits, including:
EEO Statement
Employment decisions at the Company are made without unlawful regard to race, color, religion, creed, national origin, alienage or citizenship status, sex (including gender, pregnancy, childbirth or medical conditions related to pregnancy or childbirth), gender identity or expression, sexual orientation, national origin, ethnicity, age, physical or mental disability, legally protected genetic information, marital or partnership status, sexual and reproductive health decisions, military or veteran status, or any other status protected by applicable federal, state, or local law. This organization participates in E-Verify (E-Verify's Right to Work guidance can be found here: https://www.e-verify.gov/sites/default/files/everify/posters/IER_RighttoWorkPoster.pdf).
#LI-JJ1
This job is no longer accepting applications.
Scroll down below to view similar jobs .
Share this job with your friends
Share this job with your friends
Copyright © 2024 Grabjobs Pte.Ltd. All Rights Reserved.